NCT00097149

Brief Summary

Cleft lip and palate are a significant component of morbid human birth defects in the developing world. This study measures the impact of having a child born with a cleft lip on subsequent maternal/infant family health, and whether frequent pediatric care compared to standard pediatric care will reduce neonatal mortality in children born with cleft lip and palate.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
696

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2003

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2003

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

November 17, 2004

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 18, 2004

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2006

Completed
Last Updated

December 17, 2013

Status Verified

December 1, 2013

First QC Date

November 17, 2004

Last Update Submit

December 16, 2013

Conditions

Keywords

Congenital birth defectsCleft lipCleft palateGlobal NetworkNeurodevelopmental outcomeMaternal and child healthInternationalWomen's healthBrazilBrasilLatin AmericaECLAMCArgentinaBoliviaChileColombiaEcuadorVenezuela

Outcome Measures

Primary Outcomes (3)

  • SUBPROJECT A: Neonatal mortality

  • SUBPROJECT B: Neurodevelopmental outcome

  • Weight

Secondary Outcomes (2)

  • SUBPROJECT A: Hospitalizations, Weight

  • SUBPROJECT B: Height, Speech, Hearing, Mortality, Cleft surgery, Rate of weight gain, Financial burden, Syndromic classification, Emotional and social family development

Interventions

Eligibility Criteria

AgeUp to 2 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Subproject A: * All children born with an oral cleft in a participating hospital (hospitals in Argentina, Bolivia, Brazil, Chile, Colombia and Venezuela affiliated with ECLAMC) Subproject B: Cases from Subproject A that meet the following criteria: * Cleft lip with or without cleft palate or cleft palate only * Birth weight \>2500 g * No other identifiable birth defect: nonsyndromic * Singleton (nonmultiple birth) * No other complications requiring systematic care

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Latin-American Collaborative Study of Congenital Malformations (ECLAMC)

Rio de Janeiro, Brazil

Location

Related Publications (2)

  • Wehby GL, Castilla EE, Goco N, Rittler M, Cosentino V, Javois L, Kindem M, Chakraborty H, Dutra G, Lopez-Camelo JS, Orioli IM, Murray JC. The effect of systematic pediatric care on neonatal mortality and hospitalizations of infants born with oral clefts. BMC Pediatr. 2011 Dec 28;11:121. doi: 10.1186/1471-2431-11-121.

  • Wehby GL, Castilla EE, Goco N, Rittler M, Cosentino V, Javois L, McCarthy AM, Bobashev G, Litavecz S, Mariona A, Dutra G, Lopez-Camelo JS, Orioli IM, Murray JC. Description of the methodology used in an ongoing pediatric care interventional study of children born with cleft lip and palate in South America [NCT00097149]. BMC Pediatr. 2006 Mar 24;6:9. doi: 10.1186/1471-2431-6-9.

Related Links

MeSH Terms

Conditions

Cleft LipCleft PalateCongenital Abnormalities

Condition Hierarchy (Ancestors)

Lip DiseasesMouth DiseasesStomatognathic DiseasesMouth AbnormalitiesStomatognathic System AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesJaw AbnormalitiesJaw DiseasesMusculoskeletal DiseasesMaxillofacial AbnormalitiesCraniofacial AbnormalitiesMusculoskeletal Abnormalities

Study Officials

  • Jeff Murray, M.D.

    University of Iowa

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2004

First Posted

November 18, 2004

Study Start

May 1, 2003

Study Completion

May 1, 2006

Last Updated

December 17, 2013

Record last verified: 2013-12

Locations